Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

A human translational model based on neuroplasticity for pharmacological agents potentially effective in Treatment-Resistant Depression: focus on dopaminergic system.

Collo G, Merlo Pich E.

Neural Regen Res. 2020 Jun;15(6):1027-1029. doi: 10.4103/1673-5374.270305. Review. No abstract available.

2.

The novel hybrid agonist HyNDA-1 targets the D3R-nAChR heteromeric complex in dopaminergic neurons.

Matera C, Bono F, Pelucchi S, Collo G, Bontempi L, Gotti C, Zoli M, De Amici M, Missale C, Fiorentini C, Dallanoce C.

Biochem Pharmacol. 2019 May;163:154-168. doi: 10.1016/j.bcp.2019.02.019. Epub 2019 Feb 14.

PMID:
30772268
3.
4.
5.

Genetic variation in CHRNA7 and CHRFAM7A is associated with nicotine dependence and response to varenicline treatment.

Cameli C, Bacchelli E, De Paola M, Giucastro G, Cifiello S, Collo G, Cainazzo MM, Pini LA, Maestrini E, Zoli M.

Eur J Hum Genet. 2018 Dec;26(12):1824-1831. doi: 10.1038/s41431-018-0223-2. Epub 2018 Aug 8.

6.

Alpha6-Containing Nicotinic Acetylcholine Receptors Mediate Nicotine-Induced Structural Plasticity in Mouse and Human iPSC-Derived Dopaminergic Neurons.

Collo G, Cavalleri L, Zoli M, Maskos U, Ratti E, Merlo Pich E.

Front Pharmacol. 2018 Jun 1;9:572. doi: 10.3389/fphar.2018.00572. eCollection 2018.

7.

Ketamine enhances structural plasticity in human dopaminergic neurons: possible relevance for treatment-resistant depression.

Collo G, Merlo Pich E.

Neural Regen Res. 2018 Apr;13(4):645-646. doi: 10.4103/1673-5374.230288. No abstract available.

8.

Ketamine effects on mammalian target of rapamycin signaling in the mouse limbic system depend on functional dopamine D3 receptors.

Chiamulera C, di Chio M, Cavalleri L, Venniro M, Padovani L, Collo G.

Neuroreport. 2018 May 23;29(8):615-620. doi: 10.1097/WNR.0000000000001008.

PMID:
29570499
9.

Ropinirole and Pramipexole Promote Structural Plasticity in Human iPSC-Derived Dopaminergic Neurons via BDNF and mTOR Signaling.

Collo G, Cavalleri L, Bono F, Mora C, Fedele S, Invernizzi RW, Gennarelli M, Piovani G, Kunath T, Millan MJ, Merlo Pich E, Spano P.

Neural Plast. 2018 Feb 4;2018:4196961. doi: 10.1155/2018/4196961. eCollection 2018.

10.

Ketamine enhances structural plasticity in mouse mesencephalic and human iPSC-derived dopaminergic neurons via AMPAR-driven BDNF and mTOR signaling.

Cavalleri L, Merlo Pich E, Millan MJ, Chiamulera C, Kunath T, Spano PF, Collo G.

Mol Psychiatry. 2018 Apr;23(4):812-823. doi: 10.1038/mp.2017.241. Epub 2017 Nov 21.

PMID:
29158584
11.

Expansion of human midbrain floor plate progenitors from induced pluripotent stem cells increases dopaminergic neuron differentiation potential.

Fedele S, Collo G, Behr K, Bischofberger J, Müller S, Kunath T, Christensen K, Gündner AL, Graf M, Jagasia R, Taylor V.

Sci Rep. 2017 Jul 20;7(1):6036. doi: 10.1038/s41598-017-05633-1.

12.

Geochemical behavior of an acid drainage system: the case of the Amarillo River, Famatina (La Rioja, Argentina).

Lecomte KL, Maza SN, Collo G, Sarmiento AM, Depetris PJ.

Environ Sci Pollut Res Int. 2017 Jan;24(2):1630-1647. doi: 10.1007/s11356-016-7940-2. Epub 2016 Oct 28.

PMID:
27796971
13.

Use of chondral fragments for one stage cartilage repair: A systematic review.

Bonasia DE, Marmotti A, Rosso F, Collo G, Rossi R.

World J Orthop. 2015 Dec 18;6(11):1006-11. doi: 10.5312/wjo.v6.i11.1006. eCollection 2015 Dec 18.

14.

Pharmacological targeting of dopamine D3 receptors: Possible clinical applications of selective drugs.

Pich EM, Collo G.

Eur Neuropsychopharmacol. 2015 Sep;25(9):1437-47. doi: 10.1016/j.euroneuro.2015.07.012. Epub 2015 Jul 21. Review.

PMID:
26298833
15.

Structural plasticity in mesencephalic dopaminergic neurons produced by drugs of abuse: critical role of BDNF and dopamine.

Collo G, Cavalleri L, Spano P.

Front Pharmacol. 2014 Nov 25;5:259. doi: 10.3389/fphar.2014.00259. eCollection 2014. Review.

16.

Dopamine D3 receptor ligands for drug addiction treatment: update on recent findings.

Le Foll B, Collo G, Rabiner EA, Boileau I, Merlo Pich E, Sokoloff P.

Prog Brain Res. 2014;211:255-75. doi: 10.1016/B978-0-444-63425-2.00011-8. Review.

PMID:
24968784
17.

Nicotine-induced structural plasticity in mesencephalic dopaminergic neurons is mediated by dopamine D3 receptors and Akt-mTORC1 signaling.

Collo G, Bono F, Cavalleri L, Plebani L, Mitola S, Merlo Pich E, Millan MJ, Zoli M, Maskos U, Spano P, Missale C.

Mol Pharmacol. 2013 Jun;83(6):1176-89. doi: 10.1124/mol.113.084863. Epub 2013 Mar 29.

PMID:
23543412
18.

Workplace drug testing in Italy - critical considerations.

Vignali C, Stramesi C, Morini L, Pozzi F, Collo G, Groppi A.

Drug Test Anal. 2013 Apr;5(4):208-12. doi: 10.1002/dta.1458. Epub 2013 Jan 25.

PMID:
23355251
19.

Human cartilage fragments in a composite scaffold for single-stage cartilage repair: an in vitro study of the chondrocyte migration and the influence of TGF-β1 and G-CSF.

Marmotti A, Bonasia DE, Bruzzone M, Rossi R, Castoldi F, Collo G, Realmuto C, Tarella C, Peretti GM.

Knee Surg Sports Traumatol Arthrosc. 2013 Aug;21(8):1819-33. doi: 10.1007/s00167-012-2244-7. Epub 2012 Nov 10.

PMID:
23143386
20.

Arthroscopic ankle arthrodesis: a review.

Cottino U, Collo G, Morino L, Cosentino A, Gallina V, Deregibus M, Tellini A.

Curr Rev Musculoskelet Med. 2012 Jun;5(2):151-5. doi: 10.1007/s12178-012-9119-x.

21.

Posterior ankle and subtalar arthroscopy: indications, technique, and results.

Gasparetto F, Collo G, Pisanu G, Villella D, Drocco L, Cerlon R, Bonasia DE.

Curr Rev Musculoskelet Med. 2012 Jun;5(2):164-70. doi: 10.1007/s12178-012-9118-y.

22.

Treatment of medial and posteromedial knee instability: indications, techniques, and review of the results.

Bonasia DE, Bruzzone M, Dettoni F, Marmotti A, Blonna D, Castoldi F, Gasparetto F, D'Elicio D, Collo G, Rossi R.

Iowa Orthop J. 2012;32:173-83. Review.

23.

Redistribution of DAT/α-synuclein complexes visualized by "in situ" proximity ligation assay in transgenic mice modelling early Parkinson's disease.

Bellucci A, Navarria L, Falarti E, Zaltieri M, Bono F, Collo G, Spillantini MG, Missale C, Spano P.

PLoS One. 2011;6(12):e27959. doi: 10.1371/journal.pone.0027959. Epub 2011 Dec 7. Erratum in: PLoS One. 2012;7(1). doi:10.1371/annotation/58679d17-c619-4f13-b11f-146dacfe7e92. Grazia, Maria [corrected to Spillantini, Maria Grazia].

24.

Pre-synaptic dopamine D(3) receptor mediates cocaine-induced structural plasticity in mesencephalic dopaminergic neurons via ERK and Akt pathways.

Collo G, Bono F, Cavalleri L, Plebani L, Merlo Pich E, Millan MJ, Spano PF, Missale C.

J Neurochem. 2012 Mar;120(5):765-78. doi: 10.1111/j.1471-4159.2011.07618.x. Epub 2012 Jan 23.

25.

Clinical Governance: myth, hurdle, or new opportunity?

Collo G, Bonasia DE, Castoldi F, Massazza G.

Aging Clin Exp Res. 2011 Apr;23(2 Suppl):15-6.

PMID:
21970908
26.

The tyrosine phosphatase Shp-2 interacts with the dopamine D(1) receptor and triggers D(1) -mediated Erk signaling in striatal neurons.

Fiorentini C, Mattanza C, Collo G, Savoia P, Spano P, Missale C.

J Neurochem. 2011 Apr;117(2):253-63. doi: 10.1111/j.1471-4159.2011.07196.x. Epub 2011 Feb 24.

27.

The neurobiology of dopamine receptors: evolution from the dual concept to heterodimer complexes.

Missale C, Fiorentini C, Collo G, Spano P.

J Recept Signal Transduct Res. 2010 Oct;30(5):347-54. doi: 10.3109/10799893.2010.506192. Review.

PMID:
20684667
28.

Dopamine D3 receptor-preferring agonists increase dendrite arborization of mesencephalic dopaminergic neurons via extracellular signal-regulated kinase phosphorylation.

Collo G, Zanetti S, Missale C, Spano P.

Eur J Neurosci. 2008 Oct;28(7):1231-40. doi: 10.1111/j.1460-9568.2008.06423.x.

PMID:
18973551
29.

Alpha-synuclein aggregation and cell death triggered by energy deprivation and dopamine overload are counteracted by D2/D3 receptor activation.

Bellucci A, Collo G, Sarnico I, Battistin L, Missale C, Spano P.

J Neurochem. 2008 Jul;106(2):560-77. doi: 10.1111/j.1471-4159.2008.05406.x. Epub 2008 Apr 10.

30.

Immature neuronal phenotype derived from mouse skin precursor cells differentiated in vitro.

Collo G, Goffi F, Merlo Pich E, Baldelli P, Benfenati F, Spano P.

Brain Res. 2006 Sep 13;1109(1):32-6. Epub 2006 Jul 21.

PMID:
16859654
31.

The NMDA/D1 receptor complex as a new target in drug development.

Missale C, Fiorentini C, Busi C, Collo G, Spano PF.

Curr Top Med Chem. 2006;6(8):801-8. Review.

PMID:
16719818
32.

[Current surgical treatment of lumbar instability].

Rossi P, Rosso V, Trucchi F, Collo GL.

Reumatismo. 2006 Jan-Mar;58 Spec No.1:98-9. Italian. No abstract available.

PMID:
23631074
33.

Loss of synaptic D1 dopamine/N-methyl-D-aspartate glutamate receptor complexes in L-DOPA-induced dyskinesia in the rat.

Fiorentini C, Rizzetti MC, Busi C, Bontempi S, Collo G, Spano P, Missale C.

Mol Pharmacol. 2006 Mar;69(3):805-12. Epub 2005 Dec 19.

PMID:
16365282
34.

Mouse dendritic cells express the P2X7 purinergic receptor: characterization and possible participation in antigen presentation.

Mutini C, Falzoni S, Ferrari D, Chiozzi P, Morelli A, Baricordi OR, Collo G, Ricciardi-Castagnoli P, Di Virgilio F.

J Immunol. 1999 Aug 15;163(4):1958-65.

35.
36.

Blockade of human P2X7 receptor function with a monoclonal antibody.

Buell G, Chessell IP, Michel AD, Collo G, Salazzo M, Herren S, Gretener D, Grahames C, Kaur R, Kosco-Vilbois MH, Humphrey PP.

Blood. 1998 Nov 15;92(10):3521-8.

PMID:
9808543
37.

Differential onset of expression of alpha 7 and beta 1D integrins during mouse heart and skeletal muscle development.

Brancaccio M, Cabodi S, Belkin AM, Collo G, Koteliansky VE, Tomatis D, Altruda F, Silengo L, Tarone G.

Cell Adhes Commun. 1998 Mar;5(3):193-205.

PMID:
9686317
38.
39.

ATP-mediated cytotoxicity in microglial cells.

Ferrari D, Chiozzi P, Falzoni S, Dal Susino M, Collo G, Buell G, Di Virgilio F.

Neuropharmacology. 1997 Sep;36(9):1295-301.

PMID:
9364484
40.

Tissue distribution of the P2X7 receptor.

Collo G, Neidhart S, Kawashima E, Kosco-Vilbois M, North RA, Buell G.

Neuropharmacology. 1997 Sep;36(9):1277-83.

PMID:
9364482
41.

Spontaneous cell fusion in macrophage cultures expressing high levels of the P2Z/P2X7 receptor.

Chiozzi P, Sanz JM, Ferrari D, Falzoni S, Aleotti A, Buell GN, Collo G, Di Virgilio F.

J Cell Biol. 1997 Aug 11;138(3):697-706. Erratum in: J Cell Biol 1997 Oct 20;139(2):following 571.

42.

The permeabilizing ATP receptor, P2X7. Cloning and expression of a human cDNA.

Rassendren F, Buell GN, Virginio C, Collo G, North RA, Surprenant A.

J Biol Chem. 1997 Feb 28;272(9):5482-6.

44.

P2X receptors: an emerging channel family.

Buell G, Collo G, Rassendren F.

Eur J Neurosci. 1996 Oct;8(10):2221-8. Review. No abstract available.

PMID:
8921315
45.

[Interstitial pulmonitis due to the cytomegalovirus in an immunocompetent adolescent: treatment with ganciclovir].

Pellegrini G, Collo G, Barbi M, Binda A, Masarone M.

Pediatr Med Chir. 1996 May-Jun;18(3):315-7. Review. Italian.

PMID:
8966135
46.

Cloning OF P2X5 and P2X6 receptors and the distribution and properties of an extended family of ATP-gated ion channels.

Collo G, North RA, Kawashima E, Merlo-Pich E, Neidhart S, Surprenant A, Buell G.

J Neurosci. 1996 Apr 15;16(8):2495-507.

47.

P2X1 receptor activation in HL60 cells.

Buell G, Michel AD, Lewis C, Collo G, Humphrey PP, Surprenant A.

Blood. 1996 Apr 1;87(7):2659-64.

PMID:
8639881
48.

An antagonist-insensitive P2X receptor expressed in epithelia and brain.

Buell G, Lewis C, Collo G, North RA, Surprenant A.

EMBO J. 1996 Jan 2;15(1):55-62.

49.

Gradient of integrin alpha 6A distribution in the myocardium during early heart development.

Collo G, Domanico SZ, Klier G, Quaranta V.

Cell Adhes Commun. 1995 May;3(2):101-13.

PMID:
7583004
50.

Supplemental Content

Support Center